Georgia's Online Cancer Information Center

Hematologic Malignancies Clinical Trials in Georgia

**Clinical trials are research studies that involve people. These studies test new ways to prevent, detect, diagnose, or treat diseases. People who take part in cancer clinical trials have an opportunity to contribute to scientists’ knowledge about cancer and to help in the development of improved cancer treatments. They also receive state-of-the-art care from cancer experts... Click here to learn more about clinical trials.
Cancer Type = Hematologic Malignancies
Cancer Type = Hematologic Malignancies
There are currently 4 active Hematologic Malignancies clinical trials in Georgia.
1.
A Phase III Safety Study of Ferumoxytol Compared to Ferric Carboxymaltose for the Treatment of Iron Deficiency Anemia (IDA) (FIRM)
Cancer Type
Hematologic Malignancies
NCT ID
NCT02694978
Protocol IDs
AMAG-FER-IDA-304
2.
Modular Phase II Study to Link Targeted Therapy to Patients With Pathway Activated Tumors: Module 4 - LGX818 for Patients With BRAFV600 Mutated Tumors
Cancer Type
Hematologic Malignancies
NCT ID
NCT01981187
Protocol IDs
CLGX818AUS03
Treatment Sites (1)
3.
Prospective Observational Study Of Patients With Polycythemia Vera In US Clinical Practices (REVEAL)
Cancer Type
Hematologic Malignancies
NCT ID
NCT02252159
Protocol IDs
INCB-MA-PV-401
4.
NCORP Trial
Protocol For A Research Database For Hematopoietic Stem Cell Transplantation and Marrow Toxic Injuries
Cancer Type
Hematologic Malignancies
NCT ID
NCT01166009
Protocol IDs
NMDP IRB-1999-0021
Treatment Sites (1)
Northside Hospital Cancer Institute
Atlanta
Northside Hospital Central Research Department
404-303-3355
Georgia CORE

 

Advancing Cancer Care through Partnerships and Innovation

Georgia CORE is a statewide nonprofitthat leverages partnerships and innovation to attract more clinical trials, increase research, and promote education and early detection to improve cancer care for Georgians in rural, urban, and suburban communities across the state.